*Dear Sir,*

*Enterobacter cloacae* complex (ECC), comprising at least five species (*Enterobacter cloacae*, *Enterobacter kobei*, *Enterobacter asburiae*, *Enterobacter hormaechei* and *Enterobacter ludwigii*) with different subspecies, has emerged as one of the important nosocomial pathogens in the last decade, responsible for 65%--75% of all infections due to *Enterobacter* species [@bib1]. Recently, some potentially high-risk international clones causing nosocomial infections were revealed in a Europe-wide survey [@bib2]. In this study, we characterized a CTX-M-12-producing ECC clone responsible for severe infections circulating in northeast China.

Three ECC strains were isolated from bronchoalveolar lavage (ECC3018), blood (ECC3026) and abscesses (ECC3047) of three patients admitted to a secondary hospital in a northeast province (Liaoning) in China. The isolates were further identified as *E. kobei* by *hsp60* typing [@bib3]. The three strains exhibited similar antimicrobial profiles determined by the agar dilution method ([Table 1](#tbl1){ref-type="table"}). They showed an extended spectrum β-lactamase-positive and AmpC-overexpression phenotype detected as previously reported [@bib2]. Multilocus sequence typing with use of seven loci (*dnaA*, *fusA*, *gyrB*, *leuS*, *pyrG*, *rplB* and *rpoB*) detected a new profile (3-3-110-32-19-16-17) for all isolates, and was assigned as ST591 by the PubMLST database (<https://pubmlst.org/ecloacae/>).

Isolates were sequenced using Illumina Hiseq2500 (Illumina, San Diego, CA, USA) using 2 × 125-bp pair-end libraries. Genomes were assembled by CLC [genomic workbench]{.smallcaps} v8.0, and annotated by the RAST service (<http://rast.nmpdr.org/>). To analyse the resistome, genomic sequences were uploaded to [Resfinder]{.smallcaps} (<https://cge.cbs.dtu.dk>). The three isolates shared an identical resistome comprising 19 genes, including: *aac(3)-IId*, *aac(6′)-II*, *aadA2*, *aadA16*, *aph(3′)-Ic* and *armA* for aminoglycoside resistance; *bla*~CTX-M-12~, *bla*~CARB-2~, *bla*~TEM-1~ and an unnamed *bla*~ACT~ gene for β-lactam resistance; and other genes for various drug resistance (*fosA*, *msr*(E), *mph*(A), *mph*(E), *ere*(B), *sul1*, *sul2*, *cmlA1*, *dfrA1*). The genotypes can fully explain the results of susceptibility tests.

The *bla*~CTX-M-12~ is a rare CTX-M gene, and its genetic environment was identical in the three strains ([Fig. 1](#fig1){ref-type="fig"}a). An IS*Ecp1* was located 48-bp upstream of *bla*~CTX-M-12~, and the structure was identical to that of *Escherichia coli* isolates (DQ658220) identified in Korea. The transposition unit IS*Ecp*1-*bla*~CTX-M-12~-*orf477* was highly similar to the well-reported typical *bla*~CTX-M-15~ transposition unit with a length of 2971 bp. The unit was integrated into the chromosome, located upstream of a pseudo gene and downstream of a gene encoding an asparaginyl-tRNA synthetase. Two 5-bp direct repeats TATTA were identified adjacent to the flanking left inverted repeat and putative right inverted repeat ([Fig. 1](#fig1){ref-type="fig"}a), suggesting that IS*Ecp*1 mediated the chromosomal integration of *bla*~CTX-M-12~.

The *bla*~CTX-M-12~ gene was first detected from a *Klebsiella pneumoniae* outbreak clone in Kenya in 2001 [@bib4], and was later identified in *Escherichia coli* and *K. pneumoniae* isolates from Colombia and Korea, respectively [@bib5], [@bib6]. To our knowledge, this is the first report of *bla*~CTX-M-12~ identified in *E. kobei*. As the geographic area where our strains isolated is bounded on the south by Korea, it is possible that the emergence of *bla*~CTX-M-12~ may be due to cross-border spread. Further surveillance for *bla*~CTX-M-12~ should be carried out to test this hypothesis. Additionally, among *Enterobacteriaceae*, chromosome-encoded CTX-Ms are frequently found in *Escherichia coli*, *K. pneumoniae* and *Proteus mirabilis*, but are very rare in ECC [@bib7]. Additionally, this is the first evidence of chromosomal integration of *bla*~CTX-M-12~, which had previously been exclusively detected in plasmids. This suggests the role of chromosomal locations in the spread of *bla*~CTX-M-12~.

The three isolates showed high MIC values of amikacin (\>256 mg/L). A 16S rRNA methylase gene *armA* was detected in a Tn*1548*-like segment in the isolates responsible for the amikacin resistance ([Fig. 1](#fig1){ref-type="fig"}b). This Tn*1548*-like segment consisted of a 3\'-end conserved region and a 5\'-end class 1 integron. The conserved region was structured as IS*CR1*-IS*Ec28*-*armA*-IS*Ec29*-*msr*(E)-*mph*(E), and the variable region of class 1 integron carried *aac(6\')-II* and *aadA16*. Notably, the region from an IS*26-*disrupted *intl1* gene to an IS*Aba24* was identical to that identified in *Acinetobacter baumannii* strain A071 (KT317079) ([Fig. 1](#fig1){ref-type="fig"}b). Both ends of the Tn*1548*-like segment were disrupted by IS*26*, indicating that IS*26* mediated the mobilization of this composite transposon cross species. The concomitance of extended spectrum β-lactamases and 16S rRNA methylases raises clinical concern and may become a major therapeutic threat in the future.

The genetic diversity of the three strains was determined by single-nucleotide polymorphism (SNP) analysis as described previously [@bib8], and they differed by 57 SNPs (see [Supplementary material, Table S1](#appsec1){ref-type="sec"}). This excludes the possibility of a recent transmission among the three patients, suggesting a clonal dissemination in the region. To investigate whether the genetic differences were associated with alterations of biological function, biofilm formation was tested by microtitre plate assay as described previously [@bib9]. Intriguingly, ECC3018 could form four- to ten-fold more biofilm (24 h 0.12 ± 0.02; 48 h 0.18 ± 0.04) than the other two (24 h 0.012 ± 0.003, 0.011 ± 0.002; 48 h 0.048 ± 0.03, 0.037 ± 0.02) (p \<0.05) at 37°C. The discrepancy could be explained by multiple non-synonymous SNPs identified in the genes involved in biofilm formation (see [Supplementary material, Table S1](#appsec1){ref-type="sec"}), including *barA* encoding a sensory histidine kinase [@bib10], *kefA* encoding a potassium efflux system [@bib11] and *malT* encoding a transcriptional activator of maltose regulon [@bib12]. Additionally, more non-synonymous SNPs than synonymous ones (36 versus 12) were identified in the clone frequently associated with genes involved in metabolism, membrane and pathogenicity. This implicates that the clone underwent positive selections resulting in pathogenicity diversification.

In summary, this study raises the concern that a wide repertoire of resistance mechanism and enhanced pathogenicity detected in the novel *E. kobei* clone increases its epidemic potential, and highlights the necessity of surveillance on the potential high-risk clone in the future.
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###### 

MICs of some antibiotic agents for *Enterobacter kobei* isolates

Table 1

                            ECC3018   ECC3026   ECC3047
  ------------------------- --------- --------- ---------
  Ampicillin                \>512     \>512     \>512
  Ampicillin-sulbactam      64/32     32/16     32/16
  Ciprofloxacin             0.006     0.006     0.003
  Levofloxacin              0.03      0.03      ≤0.015
  Fosfomycin                32        16        16
  Piperacillin              256       256       256
  Piperacillin-tazobactam   8/4       8/4       4/4
  Amikacin                  \>256     \>256     \>256
  Gentamycin                128       128       128
  Cefepime                  4         8         8
  Cefotaxime                4         4         4
  Cefoperazone-sulbactam    64/32     64/32     32/16
  Ceftriaxone               32        16        32
  Ceftazidime               1         1         1
  Cefoxitin                 128       128       128
  Cefazolin                 \>128     \>128     \>128
  Cefuroxime                \>128     \>128     \>128
  Meropenem                 ≤0.015    ≤0.015    0.03
  Imipenem                  0.25      0.25      0.25
